Mylan Pharmaceuticals Inc v. Merck Sharp & Dohme Corp

Michael H. Teschner

Mylan challenges Merck's sitagliptin diabetes drug patent. Prior art cited for anticipation & obviousness of its crystalline phosphate salt claims.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Roberta Pollock	400+	70%	69%
Sheridan K Snedden	500+	65%	73%
Timothy G Majors	100+	79%	59%

Name	Ratings
Mylan Pharmaceuticals Inc	L5 A
Sun Pharmaceuticals Industries Ltd	L3 B
DR Reddy's Laboratories Ltd	L3 C
DR Reddys Laboratories Inc	L3 C

Name	Ratings
Winston & Strawn LLP	L5 C
Jovial Wong	L3 A
Goodwin Procter LLP	L5 E
Keith A. Zullow	L1 C
Lerner David Littenberg Krumholz & Mentlik LLP	L4 E
Michael H. Teschner	L4 E
Tedd W. van Buskirk	L3 B
Russell W. Faegenburg	-- -- --
Katten Muchin Rosenman LLP	L2 E
Jitendra Malik	L3 D
Christopher West	L1 C
Lance Soderstrom	-- -- --
Alissa M. Pacchioli	-- -- --